Xponance Inc. Cuts Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Xponance Inc. lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 35.1% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 12,483 shares of the company's stock after selling 6,757 shares during the quarter. Xponance Inc.'s holdings in Henry Schein were worth $855,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in HSIC. Invesco Ltd. raised its holdings in Henry Schein by 0.4% during the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock valued at $343,468,000 after buying an additional 17,552 shares during the last quarter. FMR LLC increased its position in shares of Henry Schein by 6.6% in the fourth quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after acquiring an additional 217,143 shares during the period. Geode Capital Management LLC raised its stake in shares of Henry Schein by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock valued at $218,762,000 after acquiring an additional 14,876 shares during the last quarter. Palestra Capital Management LLC bought a new position in shares of Henry Schein during the fourth quarter valued at about $182,988,000. Finally, Fiduciary Management Inc. WI raised its stake in shares of Henry Schein by 7.2% during the fourth quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after acquiring an additional 167,990 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HSIC. Piper Sandler reduced their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Leerink Partners set a $75.00 price objective on Henry Schein in a research report on Monday. Wells Fargo & Company decreased their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Robert W. Baird reaffirmed a "neutral" rating and issued a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research note on Monday. Finally, Evercore ISI lifted their price target on shares of Henry Schein from $72.00 to $78.00 and gave the company an "in-line" rating in a report on Wednesday, July 9th. Eight equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $78.36.

Henry Schein Stock Down 0.6%

Shares of NASDAQ:HSIC traded down $0.40 during midday trading on Friday, reaching $69.10. The company's stock had a trading volume of 1,177,865 shares, compared to its average volume of 1,742,467. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. The firm has a 50 day moving average of $71.80 and a 200-day moving average of $71.32. The firm has a market capitalization of $8.41 billion, a P/E ratio of 21.59, a PEG ratio of 2.24 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter in the prior year, the company earned $1.10 earnings per share. The business's revenue was down .1% compared to the same quarter last year. On average, research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.